- Home
- JAZZ vs APA Comparison
JAZZ vs APA Comparison
Compare JAZZ & APA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- APA
- Stock Information
- Founded
- JAZZ 2003
- APA 1954
- Country
- JAZZ Ireland
- APA United States
- Employees
- JAZZ N/A
- APA N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- APA Oil & Gas Production
- Sector
- JAZZ Health Care
- APA Energy
- Exchange
- JAZZ Nasdaq
- APA Nasdaq
- Market Cap
- JAZZ 6.1B
- APA 6.7B
- IPO Year
- JAZZ 2007
- APA N/A
- Fundamental
- Price
- JAZZ $102.78
- APA $16.11
- Analyst Decision
- JAZZ Strong Buy
- APA Hold
- Analyst Count
- JAZZ 13
- APA 17
- Target Price
- JAZZ $187.15
- APA $25.44
- AVG Volume (30 Days)
- JAZZ 1.6M
- APA 10.5M
- Earning Date
- JAZZ 04-30-2025
- APA 05-07-2025
- Dividend Yield
- JAZZ N/A
- APA 6.21%
- EPS Growth
- JAZZ 41.75
- APA N/A
- EPS
- JAZZ 8.65
- APA 2.27
- Revenue
- JAZZ $4,068,950,000.00
- APA $9,472,000,000.00
- Revenue This Year
- JAZZ $7.60
- APA N/A
- Revenue Next Year
- JAZZ $3.43
- APA N/A
- P/E Ratio
- JAZZ $11.88
- APA $7.10
- Revenue Growth
- JAZZ 6.12
- APA 16.45
- 52 Week Low
- JAZZ $95.49
- APA $13.58
- 52 Week High
- JAZZ $148.06
- APA $33.41
- Technical
- Relative Strength Index (RSI)
- JAZZ 31.87
- APA 41.31
- Support Level
- JAZZ $100.42
- APA $14.10
- Resistance Level
- JAZZ $104.12
- APA $16.92
- Average True Range (ATR)
- JAZZ 6.41
- APA 1.32
- MACD
- JAZZ -1.27
- APA -0.15
- Stochastic Oscillator
- JAZZ 22.51
- APA 32.77
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.